‘Terrified we’ll go backwards’: Parents fear ADHD med shortage could hit NZ

ADHD medication shortages overseas are fuelling growing concern among New Zealand families, with some already struggling to fill scripts. Global supply issues have hit countries like Australia and the UK hard, with some medications reportedly expected to remain scarce through the end of 2025.

Pharmac, New Zealand’s drug-buying agency, says it’s working to avoid a similar crisis here, but for many, the warning signs are already showing.

Upper Hutt mum Rachel Te Tau said her 7-year-old son’s medication recently became extremely hard to get. He takes a dose of Teva-brand methylphenidate, which works best for him. But now, the medication is either out of stock or on back order, leaving her and her son in a difficult situation.

“We’ve had to switch to a different medication, but it doesn’t work as well,” Rachel said. “It’s frustrating and worrying. We’ve come so far with his treatment, and now we feel like we’re losing ground.”

Grace Jowett, a mother and advocate for neurodiversity, shared her own experience with ADHD medication shortages. Diagnosed as a child and again as an adult, she described how the process of getting diagnosed and maintaining treatment is already challenging. Now, the added stress of potential medication unavailability is overwhelming.

“Those with ADHD are often sensitive to rejection, so being denied medication after the difficult process of getting diagnosed would feel defeating,” Grace said. “It’s not just about the medicine—it’s about the support and understanding we need to thrive.”

Dr. Luke Bradford, medical director of the Royal New Zealand College of GPs, confirmed that supply issues have already hit New Zealand this year. “We’ve seen some medications being delayed or unavailable, which is concerning,” he said. “We’re working with Pharmac to find solutions, but it’s a complex issue.”

Pharmac has stated that it is monitoring the situation closely and is in communication with suppliers to ensure that patients have access to the medications they need. However, with global supply chains under pressure, the challenge remains significant.

For families like Rachel’s and Grace’s, the fear of a medication shortage is not just a hypothetical concern—it’s a daily reality. As the summer school holidays approach, the need for stability in treatment is more important than ever.

“We’re terrified that this shortage could affect our children’s ability to focus and learn during the holidays,” Rachel said. “It’s not just about school—it’s about their confidence, their relationships, and their overall well-being.”

As the situation continues to evolve, families and healthcare professionals are urging the government and pharmaceutical industry to act quickly and decisively to ensure that no one is left without the support they need.